Surgical Approaches to Thyroid Tumors

Endocrinology and Metabolism Clinics of North America

Volumn 37, Issue 2, 2008, Pages 437-455

  Gosnell, Jessica E ^a   Clark, Orlo H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPIRATION BIOPSY; CANCER RECURRENCE; CYTOLOGY; HEMATOMA; HUMAN; HYPOPARATHYROIDISM; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; POSTOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SUBTOTAL THYROIDECTOMY; SURGICAL TECHNIQUE; TECHNOLOGY; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID TUMOR; THYROIDECTOMY;

CARCINOMA, MEDULLARY; DISEASE PROGRESSION; HUMANS; MODELS, BIOLOGICAL; POSTOPERATIVE CARE; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 43849109781     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2008.02.002     Document Type: Review

References (86)

1. Gross S.D. A system of surgery. 4th edition vol. 2 (1886), HC Lea, Philadelphia p. 394
2. Reeve T.S., Delbridge L., Cohen A., et al. Total thyroidectomy. The preferred option for multinodular goiter. Ann Surg 206 (1987) 782-786
3. Lal G., Ituarte P., Kebebew E., et al. Should total thyroidectomy become the preferred procedure for surgical management of Graves' disease?. Thyroid 15 (2005) 569-574
4. Bellantone R., Lombardi C.P., Bossola M., et al. Total thyroidectomy for management of benign thyroid disease: review of 526 cases. World J Surg 26 (2002) 1468-1471
5. Zambudio A.R., Rodriguez J., Riquelme J., et al. Prospective study of postoperative complications after total thyroidectomy for multinodular goiters by surgeons with experience in endocrine surgery. Ann Surg 240 (2004) 18-25
6. Greenlee R.T., Murray T., Bolden S., et al. Cancer statistics, 2000. CA Cancer J Clin 50 (2000) 7-33
7. Sherman S.I., Angelos P., Ball D.W., et al. Thyroid carcinoma. J Natl Compr Canc Netw 5 (2007) 568-621
8. Hundahl S.A., Fleming I.D., Fremgen A.M., et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. [see comments]. Cancer 83 (1998) 2638-2648
9. Gilliland F.D., Hunt W.C., Morris D.M., et al. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 79 (1997) 564-573
10. Mazzaferri E.L. Management of low-risk differentiated thyroid cancer. Endocr Pract 13 (2007) 498-512
11. Hay I.D. Management of patients with low-risk papillary thyroid carcinoma. Endocr Pract 13 (2007) 521-533
12. Schroder D.M., Chambors A., and France C.J. Operative strategy for thyroid cancer. Is total thyroidectomy worth the price?. Cancer 58 (1986) 2320-2328
13. DeGroot L.J., Kaplan E.L., McCormick M., et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71 (1990) 414-424
14. Grant C.S., Hay I.D., Gough I.R., et al. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important?. Surgery 104 (1988) 954-962
15. Katoh R., Sasaki J., Kurihara H., et al. Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients. Cancer 70 (1992) 1585-1590
16. Carcangiu M.L., Zampi G., Pupi A., et al. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55 (1985) 805-828
17. Noguchi S., Noguchi A., and Murakami N. Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer 26 (1970) 1053-1060
18. Bilimoria K.Y., Bentrem D.J., Ko C.Y., et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246 (2007) 375-381 [discussion: 381-4]
19. Clark O.H. Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer. Ann Surg 196 (1982) 361-370
20. de Roy van Zuidewijn D.B., Songun I., Kievit J., et al. Complications of thyroid surgery. Ann Surg Oncol 2 (1995) 56-60
21. Reeve T.S., Curtin A., Fingleton L., et al. Can total thyroidectomy be performed as safely by general surgeons in provincial centers as by surgeons in specialized endocrine surgical units? Making the case for surgical training. Arch Surg 129 (1994) 834-836
22. Perzik S. The place of total thyroidectomy in the management of 909 patients with thyroid disease. Am J Surg 132 (1976) 480-483
23. Shigematsu N., Takami H., and Kubo A. Unique treatment policy for well-differentiated thyroid cancer in Japan: results of a questionnaire distributed to members of the Japanese Society of Thyroid Surgery and the International Association of Endocrine Surgeons. Endocr J 53 (2006) 829-839
24. Emerick G.T., Duh Q.Y., Siperstein A.E., et al. Diagnosis, treatment, and outcome of follicular thyroid carcinoma. Cancer 72 (1993) 3287-3295
25. Noguchi M., Kumaki T., Taniya T., et al. Bilateral cervical lymph node metastases in well-differentiated thyroid cancer. Arch Surg 125 (1990) 804-806
26. Noguchi S., and Murakami N. The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am 67 (1987) 251-261
27. Noguchi S., Noguchi A., and Murakami N. Papillary carcinoma of the thyroid. II. Value of prophylactic lymph node excision. Cancer 26 (1970) 1061-1064
28. Grebe S.K., and Hay I.D. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am 5 (1996) 43-63
29. Noguchi S., Murakami N., Yamashita H., et al. Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg 133 (1998) 276-280
30. Simon D., Goretzki P.E., Witte J., et al. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 20 (1996) 860-866 [discussion: 866]
31. Harwood J., Clark O.H., and Dunphy J.E. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg 136 (1978) 107-112
32. Sywak M., Cornford L., Roach P., et al. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140 (2006) 1000-1005 [discussion: 1005-7]
33. Rossi C.R., Mocellin S., Scagnet B., et al. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol 83 (2003) 80-84
34. Caron N.R., and Clark O.H. Papillary thyroid cancer: surgical management of lymph node metastases. Curr Treat Options Oncol 6 (2005) 311-322
35. Cheah W.K., Arici C., Ituarte P.H., et al. Complications of neck dissection for thyroid cancer. World J Surg 26 (2002) 1013-1016
36. Hirabayashi R.N., and Lindsays S. Carcinoma of the thyroid gland: a statistical study of 390 patients. J Clin Endocrinol Metab 21 (1961) 1596-1610
37. Grebe S.K., and Hay I.D. Follicular thyroid cancer. Endocrinol Metab Clin North Am 24 (1995) 761-801
38. D'Avanzo A., Treseler P., Ituarte P.H., et al. Follicular thyroid carcinoma: histology and prognosis. Cancer 100 (2004) 1123-1129
39. Learoyd D.L., Marsh D.J., Richardson A.L., et al. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2. Arch Surg 132 (1997) 1022-1025
40. Schlumberger M., Abdelmoumene N., Delisle M.J., et al. Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC). Br J Cancer 71 (1995) 363-365
41. Brierley J., Tsang R., Simpson W.J., et al. Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 6 (1996) 305-310
42. Scherubl H., Raue F., and Ziegler R. Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study. J Cancer Res Clin Oncol 116 (1990) 21-23
43. Orlandi F., Caraci P., Berruti A., et al. Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer. Ann Oncol 5 (1994) 763-765
44. Russell C.F., Van Heerden J.A., Sizemore G.W., et al. The surgical management of medullary thyroid carcinoma. Ann Surg 197 (1983) 42-48
45. van Heerden J.A., Grant C.S., Gharib H., et al. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212 (1990) 395-400 [discussion: 400]
46. Dralle H., Scheumann G.F., Proye C., et al. The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentre study. J Intern Med 238 (1995) 357-361
47. Machens A., Ukkat J., Brauckhoff M., et al. Advances in the management of hereditary medullary thyroid cancer. J Intern Med 257 (2005) 50-59
48. Wells Jr. S.A., Chi D.D., Toshima K., et al. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 220 (1994) 237-247 [discussion: 247-50]
49. Saad M.F., Ordonez N.G., Rashid R.K., et al. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine (Baltimore) 63 (1984) 319-342
50. Moley J.F., and DeBenedetti M.K. Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229 (1999) 880-887 [discussion: 887-8]
51. Chong G.C., Beahrs O.H., Sizemore G.W., et al. Medullary carcinoma of the thyroid gland. Cancer 35 (1975) 695-704
52. Russell W.O., Ibanez M.L., Clark R.L., et al. Thyroid carcinoma. Classification, intraglandular dissemination, and clinicopathological study based upon whole organ sections of 80 glands. Cancer 16 (1963) 1425-1460
53. Duh Q.Y., Sancho J.J., Greenspan F.S., et al. Medullary thyroid carcinoma. The need for early diagnosis and total thyroidectomy. Arch Surg 124 (1989) 1206-1210
54. Machens A., Gimm O., Hinze R., et al. Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties. J Clin Endocrinol Metab 86 (2001) 1104-1109
55. Machens A., Niccoli-Sire P., Hoegel J., et al. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349 (2003) 1517-1525
56. Gosnell J.E., Sywak M.S., Sidhu S.B., et al. New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a. ANZ J Surg 76 (2006) 586-590
57. Learoyd D.L., Gosnell J., Elston M.S., et al. Experience of prophylactic thyroidectomy in multiple endocrine neoplasis type 2A kindreds with RET codon 804 mutations. Clin Endocrinol (Oxf) 63 (2005) 636-641
58. Machens A., Brauckhoff M., Holzhausen H.J., et al. Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 90 (2005) 3999-4003
59. Skinner M.A., Moley J.A., Dilley W.G., et al. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 353 (2005) 1105-1113
60. Kitamura Y., Shimizu K., Nagahama M., et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab 84 (1999) 4043-4049
61. Kebebew E., Greenspan F.S., Clark O.H., et al. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 103 (2005) 1330-1335
62. Green L.D., Mack L., and Pasieka J.L. Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies. J Surg Oncol 94 (2006) 725-736
63. Noppen M., Poppe K., D'Haese J., et al. Interventional bronchoscopy for treatment of tracheal obstruction secondary to benign or malignant thyroid disease. Chest 125 (2004) 723-730
64. Delbridge L. The 'neglected' nerve in thyroid surgery: the case for routine identification of the external laryngeal nerve. ANZ J Surg 71 (2001) 212-214
65. Delbridge L., and Samra J. Editorial: the 'neglected' nerve in thyroid surgery-the case for routine identification of the external laryngeal nerve. ANZ J Surg 72 (2002) 239
66. Pelizzo M.R., Toniato A., and Gemo G. Zuckerkandl's tuberculum: an arrow pointing to the recurrent laryngeal nerve (constant anatomical landmark). J Am Coll Surg 187 (1998) 333-336
67. Cody III H.S., and Shah J.P. Locally invasive, well-differentiated thyroid cancer. 22 years' experience at Memorial Sloan-Kettering Cancer Center. Am J Surg 142 (1981) 480-483
68. Yang C.C., Lee C.H., Wang L.S., et al. Resectional treatment for thyroid cancer with tracheal invasion: a long-term follow-up study. Arch Surg 135 (2000) 704-707
69. Sywak M., Pasieka J.L., McFadden S., et al. Functional results and quality of life after tracheal resection for locally invasive thyroid cancer. Am J Surg 185 (2003) 462-467
70. McCaffrey T.V., Bergstralh E.J., and Hay I.D. Locally invasive papillary thyroid carcinoma: 1940-1990. Head Neck 16 (1994) 165-172
71. Shigemitsu K., Naomoto Y., Haisa M., et al. A case of thyroid cancer involving the trachea: treatment by partial tracheal resection and repair with a latissimus dorsi musculocutaneous flap. Japn J Clin Oncol 30 (2000) 235-238
72. Flisberg K., and Lindholm T. Electrical stimulation of the human recurrent laryngeal nerve during thyroid operation. Acta Otolaryngol 263 (1969) 63-67
73. Randolph G.W., Kobler J.B., and Wilkins J. Recurrent laryngeal nerve identification and assessment during thyroid surgery: laryngeal palpation. World J Surg 28 (2004) 755-760
74. Thomusch O., Sekulla C., Walls G., et al. Intraoperative neuromonitoring of surgery for benign goiter. Am J Surg 183 (2002) 673-678
75. Dralle H., Sekulla C., Haerting J., et al. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 136 (2004) 1310-1322
76. Chan W.F., Lang B.H., and Lo C.Y. The role of intraoperative neuromonitoring of recurrent laryngeal nerve during thyroidectomy: a comparative study on 1000 nerves at risk. Surgery 140 (2006) 866-872 [discussion: 872-3]
77. Loch-Wilkinson T.J., Stalberg P.L., Sidhu S.B., et al. Nerve stimulation in thyroid surgery: is it really useful?. ANZ J Surg 77 (2007) 377-380
78. Dackiw A.P., Rotstein L.E., and Clark O.H. Computer-assisted evoked electromyography with stimulating surgical instruments for recurrent/external laryngeal nerve identification and preservation in thyroid and parathyroid operation. Surgery 132 (2002) 1100-1106 [discussion: 1107-8]
79. Chiang F.Y., Wang L.F., Huang Y.F., et al. Recurrent laryngeal nerve palsy after thyroidectomy with routine identification of the recurrent laryngeal nerve. Surgery 137 (2005) 342-347
80. Karlan M.S., Catz B., Dunkelman D., et al. A safe technique for thyroidectomy with complete nerve dissection and parathyroid preservation. Head Neck Surg 6 (1984) 1014-1019
81. Mattig H., Bildat D., and Metzger B. [Reducing the rate of recurrent nerve paralysis by routine exposure of the nerves in thyroid gland operations]. Zentralbl Chir 123 (1998) 17-20 [in German]
82. Wagner H.E., and Seiler C. Recurrent laryngeal nerve palsy after thyroid gland surgery. Br J Surg 81 (1994) 226-228
83. Kouvaraki M.A., Lee J.E., Shapiro S.E., et al. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery 136 (2004) 1183-1191
84. Triponez F., Poder L., Zarnegar R., et al. Hook needle-guided excision of recurrent differentiated thyroid cancer in previously operated neck compartments: a safe technique for small, nonpalpable recurrent disease. J Clin Endocrinol Metab 91 (2006) 4943-4947
85. Torlontano M., Attard M., Crocetti U., et al. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 89 (2004) 3402-3407
86. Dieffenbach J.H. Die operative Chirugie: Die operation des Kropfes vol. 2 (1848), FA Brokhaus, Leipzig (Germany) p. 340